Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference
January 05 2021 - 10:00AM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to listen to two webcasts of discussions with Pfizer leadership at
the 39th Annual J.P. Morgan Healthcare Conference to be held
virtually.
Albert Bourla, Chairman and Chief Executive Officer, will
participate in a fireside chat presentation on Tuesday, January 12,
2021 at 10:00 a.m. EST.
Angela Hwang, Group President, Pfizer Biopharmaceuticals Group,
will participate in a COVID-19 Vaccines Keynote Panel on Wednesday,
January 13, 2021 at 12:45 p.m. EST.
To listen to the webcasts, visit our web site at
www.pfizer.com/investors. Information on accessing and registering
for the webcasts will be available at www.pfizer.com/investors
beginning today.
Visitors will be able to listen to an archived copy of the
webcasts at www.pfizer.com/investors.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 170 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated operating and financial performance; business plans and
prospects; expectations for our product pipeline; in-line products
and product candidates, including anticipated regulatory
submissions, data read-outs, study starts, approvals, revenue
contribution, growth, performance, timing of exclusivity and
potential benefits; manufacturing and product supply; our efforts
to respond to COVID-19, including our investigational vaccine
against SARS-CoV-2 and our investigational protease inhibitor; our
expectations regarding the impact of COVID-19; our ability to
successfully capitalize on growth opportunities and prospects;
plans for and prospects of our acquisitions and other business
development activities; and plans relating to share repurchases and
dividends, among other things, that are subject to substantial
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements. A
description of these risks and uncertainties can be found in
Pfizer’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2019 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned “Risk Factors” and
“Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005119/en/
Media Relations:
Amy Rose +1 (646) 592-3157 Amy.Rose@Pfizer.com Investor Relations: Bryan Dunn +1 (212) 733-8917 Bryan.Dunn@Pfizer.com
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024